Randomized, single-blinded, placebo-controlled, parallel-group trial to clarify the acute effect of single nebulized Amphotericin B on cough symptoms in bronchodilator resistive cough patients
Not Applicable
- Conditions
- Bronchodilator resistive chronic cough
- Registration Number
- JPRN-UMIN000009007
- Lead Sponsor
- Ishikawa-ken Saiseikai Kanazawa Hospital.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 28
Inclusion Criteria
Not provided
Exclusion Criteria
1)Patients having abnormal shadow on chest X-ray 2)Patients having wheezing audible 3)Patients having obstructive disorders in pulmonary function testing 4)Patients having severe complications 5)Patients having pulmonary tuberclosis
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To evaluate cough symptoms using CHQ scores
- Secondary Outcome Measures
Name Time Method To compare the pattern of change in CHQ and FENO after treatment between FACC and non FACC patients